Porton Biopharma Limited (PBL) is a limited liability company. It develops new vaccines, therapeutic proteins and enzyme products. It also manufactures its own licensed biopharmaceutical products to treat acute lymphoblastic leukaemia and the UK’s anthrax vaccine.

PBL works with the Department of Health and Social Care.

http://www.portonbiopharma.com/